Prothena Corp Public PRTA
NASDAQ PRTA
$9.73 +0.13 (+1.41%)
As of: Sep 4, 2026 · 1:35 PM EDT

Prothena Corp Public (PRTA) Total Non-Current Liabilities (2013 - 2026)

Prothena Corp Public (PRTA) posted quarterly Total Non-Current Liabilities of $4.8 million for Q1 2026, down 48.23% year-over-year from $9.2 million in Q1 2025, and down 13.23% quarter-over-quarter from $5.5 million in Q4 2025.

Analysis

Prothena Corp Public (PRTA) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

Prothena Corp Public's Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $4.8 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities fell 48.23% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $4.8 million (down 48.23% YoY), while the FY2025 annual figure was $5.5 million, down 53.03% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $4.8 million, down from $5.5 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $106.0 million in Q1 2022, with the low at $4.8 million in Q1 2026.
  • The 5-year median for Total Non-Current Liabilities is $67.4 million (2023), against an average of $50.2 million.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities advanced 7.25% in 2022, then tumbled 88.14% in 2025.
  • Prothena Corp Public's Total Non-Current Liabilities stood at $85.8 million in 2022, then slipped by 8.99% to $78.1 million in 2023, then tumbled by 85.05% to $11.7 million in 2024, then sank by 53.03% to $5.5 million in 2025, then decreased by 13.23% to $4.8 million in 2026.
  • Business Quant data shows PRTA's Total Non-Current Liabilities at $4.8 million in Q1 2026, $5.5 million in Q4 2025, and $6.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn 40.00 Mn
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn 3.92 Bn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 1.53 Bn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 1.88 Bn
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 9.32 Bn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 1.17 Bn
10 Prothena Corp Public 506.33 Mn 218.13 Mn - 4.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.03 Mn
Mar 31, 2026 4.76 Mn
Dec 31, 2025 5.49 Mn
Sep 30, 2025 6.20 Mn
Jun 30, 2025 6.93 Mn
Mar 31, 2025 9.20 Mn
Dec 31, 2024 11.68 Mn
Sep 30, 2024 14.47 Mn
Jun 30, 2024 16.90 Mn
Mar 31, 2024 77.53 Mn
Dec 31, 2023 78.13 Mn
Sep 30, 2023 76.32 Mn
Jun 30, 2023 67.41 Mn
Mar 31, 2023 85.29 Mn
Dec 31, 2022 85.85 Mn
Sep 30, 2022 99.19 Mn
Jun 30, 2022 102.18 Mn
Mar 31, 2022 106.03 Mn
Dec 31, 2021 109.87 Mn
Sep 30, 2021 113.03 Mn